UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549-1004
FORM 8-K
CURRENT
REPORT
PURSUANT TO SECTION 13 OR 15(d) OF
THE SECURITIES EXCHANGE ACT OF 1934
DATE OF REPORT (Date of earliest event reported): JULY 11, 2007
CIPHERGEN BIOSYSTEMS, INC.
(Exact name of Registrant as specified in its charter)
| |
|
|
|
|
| Delaware
|
|
000-31617
|
|
33-059-5156 |
| (State or other jurisdiction of
|
|
(Commission
|
|
(I.R.S. Employer |
| incorporation or organization)
|
|
File Number)
|
|
Identification Number) |
6611 Dumbarton Circle
Fremont, CA 94555
(Address of principal executive offices)
(510) 505-2100
(Registrant’s telephone number, including area code)
Check the appropriate box below if the Form 8-K filing is intended to
simultaneously satisfy the filing obligation of the registrant under any of the
following provisions (see General Instruction A.2.):
| o |
|
Written communications pursuant to Rule 425 under the Securities
Act (17 CFR 230.425) |
| |
| o |
|
Soliciting material pursuant to Rule 14a-12 under the Exchange
Act (17 CFR 240.14a-12) |
| |
| o |
|
Pre-commencement communications pursuant to Rule 14d-2(b) under the
Exchange Act (17 CFR 240.14d-2(b)) |
| |
| o |
|
Pre-commencement communications pursuant to Rule 13e-4(c) under the
Exchange Act (7 CFR 240.13e-4(c)) |
TABLE OF CONTENTS
ITEM 7.01 OTHER EVENTS
On July 11, 2007, Ciphergen issued a press release announcing that the company received from
the United States Patent and Trademark Office a notice of intent to issue a Reexamination
Certificate of U.S. patent no. 6,734,022, which is directed to a fundamental process of SELDI mass
spectrometry. Upon reissuance of the patent, Bio-Rad Laboratories is to pay Ciphergen $2.0 million
pursuant to the terms of the Asset Purchase Agreement entered into in connection with the sale of
Ciphergen’s instrumentation business to Bio-Rad on November 13, 2006.
ITEM 9.01 FINANCIAL STATEMENTS AND EXHIBITS
(d) EXHIBITS.
| |
|
|
| EXHIBIT NO. |
|
DESCRIPTION |
99.1
|
|
Press release issued by Ciphergen Biosystems, Inc. on July 11, 2007 |